Phio Pharmaceuticals Reports Positive PH-762 Skin Cancer Data
KING OF PRUSSIA, PENNSYLVANIA, March 23, 2026 Phio Pharmaceuticals Corp. has announced the presentation of positive clinical study results...
Phase 1b trial
Advertisement
J&J Pasritamig Combo Shows Strong mCRPC Activity
RARITAN, N.J., February 26, 2026 Johnson & Johnson (NYSE: JNJ) announced preliminary Phase 1b clinical results demonstrating promising antitumor...
VRON-0200 Shows Durable Immunity in HBV Trial
PHILADELPHIA, Feb. 22, 2026 — Virion Therapeutics reported new Phase 1b clinical data at the 33rd Conference on Retroviruses...
Apogee Shows Durable Phase 1b Asthma Data for IL-13 Biologic
SAN FRANCISCO & BOSTON | January 6, 2026 — Apogee Therapeutics has reported positive interim results from a Phase...
Mazdutide Shows Strong Weight-Loss Impact in Phase 1b Trial
BEIJING, December 2025 — New Phase 1b clinical data show that mazdutide, an investigational metabolic therapy, delivered significant weight-loss...
Advertisement
